Congress just gave rural America 40 days of telehealth. Then what? Let that sink in. After extending Medicare telehealth flexibilities through January 30, 2026, we're staring down another cliff that threatens to abandon rural patients. Again. Here's what happens on January 31 if Congress doesn't act: 🚫 No more virtual visits from home for rural Medicare patients 🚫 Physical therapists, occupational therapists, and speech pathologists lose telehealth billing rights entirely 🚫 Patients must travel to approved facilities for any telehealth service 🚫 FQHCs and rural health clinics can no longer serve as distant-site providers Think about the 82-year-old farmer with heart failure in Montana. The stroke survivor in rural Mississippi needing weekly speech therapy. The diabetic grandmother in West Virginia ...

The mammogram that tells your future just got FDA approval. In 2025, we crossed a remarkable threshold. The FDA authorized Clairity Breast, the first AI system that predicts your five-year breast cancer risk from a single standard mammogram. No family history questionnaires. No genetic testing. Just the imaging data you're already collecting. Think about what this means: 📊 Every routine screening becomes a risk assessment 🎯 High-risk women get identified for enhanced screening ⏰ Prevention strategies start years before cancer develops 💡 Health equity improves (no literacy barriers from questionnaires) The technology was validated on hundreds of thousands of mammograms. It doesn't just detect existing cancer, it predicts future risk based on subtle tissue patterns invisible to human eyes. Here's ...

Your AI therapist needs a prescription now. The FDA just dropped a bombshell on mental health tech companies. At their November 2025 Digital Health Advisory Committee meeting, they outlined something unprecedented: generative AI chatbots for mental health might need the same rigorous testing as antidepressants. Think about that for a second. Double-blind, placebo-controlled trials. For chatbots. 🤖 Here's what the FDA is demanding: • Predetermined Change Control Plans for every algorithm update • Real-time monitoring for "hallucinations" and harmful outputs • Evidence of equitable performance across all populations • Human escalation pathways built into every system • Potentially Class III medical device designation (the highest risk category) Why this matters: 77% of counties in America lack adequate mental health providers. ...

The FDA just changed the game for medical innovation forever. On December 1, 2025, Commissioner Marty Makary announced something unprecedented: agentic AI deployment across the entire FDA. Not just chatbots. Not just automation. We're talking about AI systems that can plan, reason, and execute complex regulatory workflows autonomously. Think about what this means: • Pre-market device reviews that take weeks, not months • Drug safety surveillance catching signals in real-time • Biologics inspections streamlined through predictive analytics • Meeting management that actually moves approvals forward The numbers are staggering. Over 70% of FDA staff are already using Elsa, their LLM tool launched in May. Now they're scaling to full agentic capabilities with human oversight built in. 💡 Here's what healthcare ...

34 years of newborn protection, gone with one committee vote. The CDC's Advisory Committee on Immunization Practices (ACIP) just voted to end universal hepatitis B vaccination at birth, reversing a policy that's been in place since 1991. Instead of vaccinating all newborns, they now recommend birth doses only for babies whose mothers test positive for hepatitis B or have unknown status. For all other infants? Start at 2 months, with "shared decision-making." 🚨 The backlash has been swift and severe. The American Academy of Pediatrics immediately condemned the decision. Major liver disease societies called it dangerous. Leading pediatricians are publicly stating they'll continue vaccinating all newborns regardless of the new guidance. Why this matters for healthcare leaders: This creates an ...

2.6 million seniors just lost their Medicare Advantage plans. That's not a typo. UnitedHealthcare, Humana, and Aetna are pulling back from Medicare Advantage in unprecedented ways for 2026: • UnitedHealthcare: Exiting 225 counties, entering only 14 • Humana: Leaving 198 counties, entering just 5 • Coverage dropping from 90% to 80% of U.S. counties 💔 The human impact is staggering. 13% of all Medicare Advantage enrollees must find new plans, up from 6% last year. Four insurers completely exited the market citing financial challenges. Why the exodus? Insurers blame "government funding cuts and rising healthcare costs." Yet UnitedHealth still posted a $2.3 billion quarterly profit. Here's what healthcare leaders need to understand: This isn't just about insurance companies and their ...

Congress just saved hospital care at home for 5 more years 🏠 On December 1, the House passed the Hospital Inpatient Services Modernization Act, extending Medicare's Acute Hospital Care at Home waiver through 2030. This was set to expire January 30, 2026. Here's what makes this massive: Over 300 hospitals across 37 states have been delivering acute-level care in patients' homes since the pandemic. Real hospital care. Real monitoring. Real results. The data is compelling: 30% reduction in hospital-acquired infections 38% lower readmission rates 20% cost savings per episode 96% patient satisfaction scores But here's the kicker: This program almost died because Congress couldn't decide if home-based acute care was "real" hospital care. Meanwhile, patients were getting IV antibiotics, continuous ...

CMS just dropped a bombshell on outpatient surgery centers. Starting in 2026, they're dismantling the Inpatient Only list over 3 years, beginning with 285 musculoskeletal procedures. But here's what nobody's talking about: 📊 ASCs get a 2.9% payment increase (barely covering inflation at 3.4%) 🏥 Over 500 procedures suddenly approved for ASC settings 💰 The 340B remedy offset continues slashing payments by 0.5% annually through 2041 This creates a fascinating paradox. CMS is pushing complex surgeries into outpatient settings while simultaneously squeezing reimbursements. They're expanding ASC procedure lists dramatically but offering payment updates that don't even match inflation. The real winners? High-volume ASCs that can capitalize on the 500 new approved procedures. The losers? Rural hospitals already struggling with the ...